"10.1371_journal.pone.0117525","plos one","2015-02-11T00:00:00Z","Allison L Naleway; Sheila Weinmann; Girishanthy Krishnarajah; Bhakti Arondekar; Jovelle Fernandez; Geeta Swamy; Evan Myers","The Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States of America; GlaxoSmithKline, North American Vaccine Development, Philadelphia and King of Prussia, PA, United States of America; Duke University Medical Center, Department of Obstetrics and Gynecology, Durham, NC, United States of America","Conceived and designed the experiments: AN SW GK BA JF GS EM. Performed the experiments: AN SW. Analyzed the data: AN SW. Contributed reagents/materials/analysis tools: AN SW. Wrote the paper: AN SW GK BA JF GS EM.","GK, BA, and JF are employees of the GlaxoSmithKline group of companies. GK, BA, and JF own restricted shares in the GlaxoSmithKline group of companies. EM has received grants and consulting fees from GlaxoSmithKline during the conduct of the study; consulting fees from Merck, Inc. for work on HPV vaccines; and grants from Gen-Probe/Hologic for work on HPV RNA testing. EM is a consultant for cervical cancer screening guidelines for the American Cancer Society Federal Advisory Panel, National Breast and Cervical Cancer Early Detection Program, and Centers for Disease Control and Prevention. GS has received consulting and lecturing fees as well as grant support for vaccine-related studies from GlaxoSmithKline, as well as for advisory boards, lectures, and the development of educational presentations. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","02","Allison L Naleway","ALN",7,TRUE,7,2,2,7,TRUE,TRUE,FALSE,0,NA,FALSE
